astrazeneca glp 1 drug AstraZeneca's oral GLP-1 scored phase 2 wins, but no data yet AstraZeneca GLP-1 pill shows promise

International Journal of Obesity (2005)

It is contraindicated in patients with cardiovascular disease, uncontrolled hypertension, hyperthyroidism, glaucoma, or history of drug abuse

In a retrospective, observational, database-based study, acetyl-l-carnitine acted synergistically with pregabalin in patients with nerve compression neuropathies [49]

Nutritional interventions leading to 5% weight loss are estimated to decrease LDL-C and non-HDL by 5%

The concentration difference is not marginal

And if we need to involve pharmaceutical intervention, it's there, there's options out there that can help patients kick start their, their health and wellness, especially people in their forties